Latest News
Yasoo Health Ltd receives a research grant from the Cyprus Research Promotion Foundation for its program on the chemoprevention and chemotherapy of prostate cancer
January 5, 2009 -Yasoo Health Ltd reported today that it has been awarded a research grant from the Cyprus Research Promotion Foundation to support its research and development work on the identification and development of chemo-preventive/chemotherapeutic agents for the prevention and treatment of prostate cancer.
Yasoo Health introduces Syndion™
October 23, 2008 -
Optimized nutritional support for neurodevelopmentally challenged children and adults with special nutritional needs and/or food sensitivities.
Yasoo Health Inc. Closes Series C Financing
August 18, 2008 – Yasoo Health Inc. (Yasoo) closes Series C Financing from Emergomed Limited.
Read More
New help for people with CF or conditions that cause malabsorption of fat-soluble vitamins
April 23, 2007- Johnson City, TN Yasoo Health Inc announced the U.S. launch of AquADEKs®, a novel nutritional supplement designed to ...
Read More
Yasoo Health; a finalist in Nutracon
March 12, 2007- AquADEKs®, a product developed by Yasoo Health, was selected as one of the three finalists in the 2007 Nutracon Award Competition
Read More
Yasoo Health Ltd. is awarded a research grant from the Cyprus Research Promotion Foundation for its cancer chemoprevention research program
February 20, 2007 -Yasoo Health Ltd (Yasoo), a subsidiary of Yasoo Health Inc., reported today that it has been awarded a research grant from the Cyprus Research Promotion Foundation (RPF, www.research.org.cy) to support its research and development work on the identification and development of chemo-preventive products for the prevention and treatment of prostate cancer.
Read More
Yasoo Health Ltd. receives a research grant from the European organization EUREKA for its Inflammatory Bowel Disease Program
February 1, 2007 - Yasoo Health Ltd (Yasoo) announced today that it has secured a research grant from the European organization EUREKA (www.eureka.be) to support its research and development work on a product for the management and adjuvant therapy of Inflammatory Bowel Disease (IBD).
Read More
Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
February 7, 2006 - Yasoo Health, Inc. announced today that it received $936,375 in financing from the Cystic Fibrosis Foundation* to develop and commercialize a "first of its kind" formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis (CF) patients.
Read More
Yasoo Health Awarded Patent
April 6, 2004 - Press Release -Yasoo Health, Inc announced today patent protection for a novel tocopherol ester derivative with selenium and other minerals.
Read More
Yasoo Health Inc. Closes Series A Financing
July 1, 2002 - Yasoo Health Inc. (Yasoo) closed Series A financing from the Bank of Cyprus Ventures and Emergo.
Read More
Yasoo Health Inc. Receives SBIR Grant
April 1, 2002 - Yasoo Health Inc. received funding from the NIH for a Small Business Innovation Research grant to develop formulations containing fat-soluble vitamins and nutrients (vitamins D3, K1 and mixed tocopherols (E), beta-carotene, linoleic and/or linolenic acids and coenzyme Q10) that will be administered to children with cystic fibrosis to alleviate complications due to the malabsorption of fat-soluble nutrients.
Read More